Lupin, the country's second-largest drug maker by revenue, posted a 41.5 per cent fall in second-quarter profit on Wednesday, hurt by higher expenses.
Net profit was 266 crore ($36.00 million) in the quarter ended September 30, compared with a profit of Rs 455 crore a year earlier, Lupin said.
Analysts on average had expected a profit of Rs 273 crore, according to Refintiv data.
Income from operations rose marginally to Rs 38,910 crore.
At 3:11 pm, Lupin shares were trading 1.4 per cent higher at Rs 879.60 apiece on the NSE, whose benchmark index Nifty was up 1.9 per cent.
($1 = Rs 73.8850)
Follow NDTV for latest election news and live coverage of assembly elections 2019 in Maharashtra and Haryana.
Subscribe to our YouTube channel, like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.